The Liz Moody Podcast cover image

Beyond Ozempic: Metabolic Dysfunction Is Impacting Fertility, Weight, & Energy (+ A Stanford MD’s Plan To Fix It)

The Liz Moody Podcast

00:00

Long-Term Safety of GLP-1 Agonists and Healthcare Challenges

Discussion on the long-term safety of GLP-1 agonists like Ozempic, concerns about lack of studies on the impact of these drugs on children, financial implications of Medicare funding for obesity medications, and challenges in holistic healthcare approaches amidst rising metabolic dysfunction.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app